Pharming Affirms FY2026 Sales Guidance of $405.000M-$425.000M vs $421.375M Est
Benzinga Newsdesk 6 months ago
NewsGuidance
Pharming (NASDAQ:PHAR) affirms FY2026 sales outlook from $405.000 million-$425.000 million to $405.000 million-$425.000 million vs $421.375 million estimate.
Pharming (NASDAQ:PHAR) affirms FY2026 sales outlook from $405.000 million-$425.000 million to $405.000 million-$425.000 million vs $421.375 million estimate.